Global Magnetoencephalography (MEG) Devices Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Magnetoencephalography (MEG) Devices Market was valued at USD 184 million in 2023 and is projected to reach USD 382 million by 2031, growing at a CAGR of 9.6% during the forecast period from 2023 to 2031. The MEG devices market is gaining traction due to increasing neurological disorder prevalence, advancements in non-invasive brain imaging technologies, and rising adoption of high-precision neurodiagnostic tools in research and clinical settings. As the demand for accurate, real-time brain mapping continues to rise, MEG systems are being integrated across major research institutes, hospitals, and academic centers worldwide.

Drivers:

1. Increasing Prevalence of Neurological Disorders:

The global rise in neurological diseases such as epilepsy, Alzheimer's, and Parkinson’s is a significant driver for MEG devices. These systems offer real-time data on neuronal activity, aiding early diagnosis and effective treatment planning.

2. Technological Advancements in Brain Imaging:

Ongoing innovations, including improved superconducting sensors, portable MEG devices, and AI-powered analysis tools, are enhancing the sensitivity and accessibility of MEG technology.

3. Rising Investments in Neuroscience Research:

Growing funding for brain research from government bodies and private organizations is boosting the adoption of MEG in neuroimaging and cognitive research.

Restraints:

1. High Cost and Infrastructure Requirements:

MEG systems are expensive, both in terms of initial capital investment and operational infrastructure, including magnetically shielded rooms, limiting their adoption primarily to well-funded institutions.

2. Limited Skilled Professionals:

The operation and interpretation of MEG data require specialized training, and the current shortage of skilled neuroimaging professionals poses a barrier to widespread implementation.

Opportunity:

1. Emerging Applications in Mental Health and Brain-Computer Interfaces:

The expanding role of MEG in understanding psychiatric conditions and developing brain-computer interfaces (BCIs) presents a promising growth avenue.

2. Expanding Healthcare Infrastructure in Emerging Markets:

As healthcare facilities in Asia-Pacific and Latin America continue to modernize, there is a growing opportunity to deploy MEG devices for clinical and research purposes.

Market by System Type Insights:

By system type, the Superconducting Quantum Interference Device (SQUID)-based MEG systems segment accounted for the largest market share in 2023. These systems offer ultra-sensitive brain activity measurements and have been the gold standard in MEG technology. However, the Optically Pumped Magnetometers (OPM)-based MEG systems segment is projected to witness the highest CAGR, driven by their enhanced portability, lower cost, and room-temperature operation capabilities.

Market by End-Use Insights:

In terms of end-use, the Academic and Research Institutes segment dominated the market in 2023, holding over 55% of the revenue share. MEG devices are extensively utilized in neuroscientific research for mapping brain functions and understanding cognitive processes. The Hospitals & Clinics segment is expected to grow significantly, as clinical applications for MEG expand into epilepsy surgery planning and psychiatric evaluations.

Market by Regional Insights:

North America led the global MEG devices market in 2023, driven by advanced healthcare infrastructure, strong research funding, and the presence of major market players. Europe followed closely, with countries like Germany and the UK heavily investing in neuroimaging research. Asia-Pacific is projected to grow at the fastest pace, supported by increasing healthcare investments and rising awareness of neurological diagnostics in countries such as China, Japan, and South Korea.

Competitive Scenario:

Key players in the MEG devices market include Elekta AB, Ricoh Company, Ltd., Croton Healthcare, Neuromag, Ltd., and Compumedics Limited. These companies are focused on technological innovation, strategic partnerships, and expanding their product portfolio to meet rising clinical and research demands. For instance:

In 2024, Elekta AB introduced its next-gen MEGIN TRIUX™ neo system, integrating AI algorithms for automated data analysis.

Ricoh Company launched a compact OPM-based MEG system in 2023 aimed at outpatient neurology clinics.

Compumedics Limited entered a strategic collaboration in 2022 to co-develop hybrid MEG-EEG platforms.

Scope of Work – Global Magnetoencephalography (MEG) Devices Market

Report Metric Details

Market Size (2023) USD 184 million

Projected Market Size (2031) USD 382 million

CAGR (2023–2031) 9.6%

Market Segments By System Type (SQUID, OPM), By End-Use (Hospitals, Academic Institutes), By Region

Growth Drivers Rising neurological disease burden, tech innovation, neuro research funding

Opportunities Emerging BCI applications, expanding healthcare in Asia-Pacific

Key Market Developments:

2024: Elekta AB launched an upgraded MEG platform with enhanced signal-to-noise ratio and real-time data streaming for surgical applications.

2023: Ricoh debuted its modular OPM MEG device suitable for non-shielded clinical settings.

2022: Compumedics Limited signed a distribution agreement to expand its MEG systems across Southeast Asia.

FAQs:

1) What is the current market size of the Global Magnetoencephalography (MEG) Devices Market?

The market was valued at USD 184 million in 2023.

2) What is the major growth driver of the Global Magnetoencephalography (MEG) Devices Market?

The primary growth driver is the increasing prevalence of neurological disorders and advancements in non-invasive brain imaging technologies.

3) Which is the largest region during the forecast period in the Global Magnetoencephalography (MEG) Devices Market?

North America is expected to remain the largest region due to its advanced healthcare infrastructure and research ecosystem.

4) Which segment accounted for the largest market share in Global Magnetoencephalography (MEG) Devices Market?

The SQUID-based MEG systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Magnetoencephalography (MEG) Devices Market?

Key players include Elekta AB, Ricoh Company, Ltd., Compumedics Limited, Croton Healthcare, and Neuromag, Ltd.